GALERA THERAPEUTICS INC (GRTX)
US36338D1081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 18.26M | 4.30M | 19.90M | 15.90M | 18.40M | |||
| Marketable Securities | 0.00 | 27.30M | 51.40M | 56.90M | 93.90M | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 3.37M | 6.90M | 6.20M | 5.20M | 5.30M | |||
| Total Current Assets | 21.63M | 38.50M | 77.40M | 77.90M | 117.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.28M | 500.00K | 800.00K | 1.60M | 1.70M | |||
| Goodwill | 881.00K | 900.00K | 900.00K | 900.00K | 900.00K | |||
| Intangibles | 2.26M | 2.30M | 2.30M | 2.30M | 2.30M | |||
| Other Non-Current Assets | 90.00K | 1.90M | 2.00M | 1.50M | 900.00K | |||
| Total Non-Current Assets | 4.51M | 5.50M | 5.90M | 6.20M | 5.80M | |||
| TOTAL ASSETS | 26.14M | 44.00M | 83.30M | 84.10M | 123.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.58M | 9.80M | 7.90M | 8.80M | 5.70M | |||
| Accounts Payable | 1.38M | 3.60M | 5.00M | 5.10M | 3.90M | |||
| Total Current Liabilities | 4.96M | 13.40M | 12.90M | 14.00M | 9.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 151.05M | 139.60M | 128.10M | 63.40M | 43.30M | |||
| Deferred Taxes/Income | 203.00K | 200.00K | 300.00K | 300.00K | 300.00K | |||
| Other Non-Current Liabilities | 1.12M | 0.00 | 0.00 | 400.00K | 500.00K | |||
| Total Non-Current Liabilities | 152.37M | 139.80M | 128.40M | 64.00M | 44.10M | |||
| TOTAL LIABILITIES | 157.33M | 153.20M | 141.30M | 78.00M | 53.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -437.41M | -378.30M | -316.10M | -235.60M | -161.40M | |||
| Additional Paid In Capital | 306.17M | 269.10M | 258.10M | 241.60M | 230.90M | |||
| Common Shares | 54.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 54.39M | 28.50M | 26.50M | 25.00M | 24.80M | |||
| Tangible Book Value per Share | -2.47 | -3.94 | -2.31 | 0.12 | 2.68 | |||
| Total Shareholders' Equity | -131.19M | -109.20M | -58.00M | 6.10M | 69.60M | |||
| TOTAL LIABILITIES AND EQUITY | 26.14M | 44.00M | 83.30M | 84.10M | 123.40M | |||
| Statistics | ||||||||
| Debt/Equity | -1.15 | -1.28 | -2.21 | 10.39 | 0.62 | |||
| Current Ratio | 4.36 | 2.87 | 6.00 | 5.56 | 12.12 | |||
| Return On Assets (ROA) | -226.01% | -141.41% | -96.67% | -88.25% | -47.90% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -1216.72% | -84.93% | |||
All data in USD